Additional validation of Osaka method (0.01 mol/L dithiothreitol) for negating the daratumumab interference

Transfusion. 2019 Jul;59(7):2479-2480. doi: 10.1111/trf.15305.

Affiliations

¹ Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, Japan.
² Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

PMID: 31268593
DOI: 10.1111/trf.15305

No abstract available

Publication types

Letter
Validation Study

MeSH terms

Antibodies, Monoclonal / pharmacology*
Blood Grouping and Crossmatching*
Dithiothreitol / pharmacology*
Erythrocytes / metabolism*
Humans
Multiple Myeloma / blood*

Substances

Antibodies, Monoclonal
daratumumab
Dithiothreitol